INGN Q1 2021 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$87M-1.8% YoY

Gross Profit

$40M45.9% margin

Operating Income

-$2M-2.5% margin

Net Income

-$732,000-0.8% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

+17.5%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$476M

Total Liabilities

$120M

Stockholders' Equity

$356M

Cash & Equivalents

$220M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$87M	$88M	-1.8%
Gross Profit	$40M	$38M	+3.9%
Operating Income	-$2M	-$2M	+2.2%
Net Income	-$732,000	-$2M	+53.9%

Geographic Segments

UNITED STATES

$71M82%

Non Us

$16M18%